Jacob ST, Crozier I, Fischer WA, Hewlett A, Kraft CS, Vega M-AdL, et al. Ebola virus disease. Nat Rev Dis Primers. 2020;6(1):13.
Google Scholar
Feldmann H, Geisbert TW. Ebola haemorrhagic fever. The Lancet. 2011;377(9768):849–62.
Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba NF, et al. Emergence of Zaire Ebola Virus Disease in Guinea. N Engl J Med. 2014;371(15):1418–25.
Google Scholar
Izudi J, Bajunirwe F. Case fatality rate for Ebola disease, 1976–2022: A meta-analysis of global data. J Infect Public Health. 2024;17(1):25–34.
Google Scholar
Tozay S, Fischer WA, Wohl DA, Kilpatrick K, Zou F, Reeves E, et al. Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation. Clin Infect Diseases. 2020;71(7):1749–55.
Google Scholar
Sneller MC, Reilly C, Badio M, Bishop RJ, Eghrari AO, Moses SJ, et al. A Longitudinal Study of Ebola Sequelae in Liberia. N Engl J Med. 2019;380(10):924–34.
Google Scholar
Mattia JG, Vandy MJ, Chang JC, Platt DE, Dierberg K, Bausch DG, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis. 2016;16(3):331–8.
Google Scholar
Clark DV, Kibuuka H, Millard M, Wakabi S, Lukwago L, Taylor A, et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis. 2015;15(8):905–12.
Google Scholar
Godwin CL, Wohl DA, Fischer Nd WA, Singh K, Hawks DA, Devore EE, et al. Reproductive health sequelae among women who survived Ebola virus disease in Liberia. Int J Gynaecol Obstet. 2019;146(2):212–7.
Google Scholar
Howlett PJ, Walder AR, Lisk DR, Fitzgerald F, Sevalie S, Lado M, et al. Case Series of Severe Neurologic Sequelae of Ebola Virus Disease during Epidemic. Sierra Leone Emerg Infect Dis. 2018;24(8):1412–21.
Google Scholar
Kelly JD, Ryn CV, Badio M, Fayiah T, Johnson K, Gayedyu-Dennis D, et al. Clinical Sequelae Among Individuals With Pauci-Symptomatic or Asymptomatic Ebola Virus Infection and Unrecognised Ebola Virus Disease in Liberia: A Longitudinal Cohort Study. Lancet Infect Dis. 2022;22(8):1163–71.
Google Scholar
Leligdowicz A, Fischer WA, Uyeki TM, Fletcher TE, Adhikari NKJ, Portella G, et al. Ebola virus disease and critical illness. Crit Care. 2016;20(1):217.
Google Scholar
Bah AJ, James PB, Bah N, Sesay AB, Sevalie S, Kanu JS. Prevalence of anxiety, depression and post-traumatic stress disorder among Ebola survivors in northern Sierra Leone: a cross-sectional study. BMC Public Health. 2020;20(1):1391.
Google Scholar
Lawry LL, Stroupe Kannappan N, Canteli C, Clemmer W. Mixed-methods assessment of health and mental health characteristics and barriers to healthcare for Ebola survivors in Beni, Butembo and Katwa health zones of the Democratic Republic of Congo. BMJ Open. 2021;11(8): e050349.
Google Scholar
Shantha JG, Crozier I, Yeh S. An update on ocular complications of Ebola virus disease. J Curr Ophthalmol. 2017;28(6):600–6.
Wiedemann A, Foucat E, Hocini H, Lefebvre C, Hejblum BP, Durand M, et al. Long-lasting severe immune dysfunction in Ebola virus disease survivors. Nat Commun. 2020;11(1):3730.
Google Scholar
Bwire G, Sartorius B, Guerin P, Tegegne MA, Okware SI, Talisuna AO. Sudan Ebola virus (SUDV) outbreak in Uganda, 2022: lessons learnt and future priorities for sub-Saharan Africa. BMC Med. 2023;21(1):144.
Google Scholar
Glynn M, Drake WM. Hutchison’s clinical methods: An integrated approach to clinical practice. 25th ed: London: Elsevier; 2022;9780323775847.
Chan Y, Fornace K, Wu L, Arnold BF, Priest JW, Martin DL, et al. Determining seropositivity-A review of approaches to define population seroprevalence when using multiplex bead assays to assess burden of tropical diseases. PLoS Negl Trop Dis. 2021;15(6): e0009457.
Google Scholar
Wohl DA, Fischer WA, Mei W, Zou F, Tozay S, Reeves E, et al. Post-Ebola Symptoms 7 Years After Infection: The Natural History of Long Ebola. Clin Infect Diseases. 2023;76(3):e835–40.
Bond NG, Grant DS, Himmelfarb ST, Engel EJ, Al-Hasan F, Gbakie M, et al. Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone. Clin Infect Diseases. 2021;73(6):1046–54.
Vetter P, Kaiser L, Schibler M, Ciglenecki I, Bausch DG. Sequelae of Ebola virus disease: the emergency within the emergency. Lancet Infect Dis. 2016;16(6):e82–91.
Google Scholar
Qureshi AI, Chughtai M, Loua TO, Pe Kolie J, Camara HF, Ishfaq MF, et al. Study of Ebola Virus Disease Survivors in Guinea. Clin Infect Diseases. 2015;61(7):1035–42.
Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis. 1999;179 Suppl 1:S28-35.
Google Scholar
Billioux BJ, Smith B, Nath A. Neurological Complications of Ebola Virus Infection. Neurotherapeutics. 2016;13(3):461–70.
Google Scholar
The PREVAIL III Study Group. A Longitudinal Study of Ebola Sequelae in Liberia. N Engl J Med. 2019;380(10):924–34.
Google Scholar
Mandizadza OO, Phebeni RT, Ji C. Prevalence of somatic symptoms among Ebola Virus Disease (EVD) survivors in Africa: a systematic review and meta-analysis. BMC Public Health. 2024;24(1):1511.
Google Scholar
Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK, et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med. 2015;372(25):2423–7.
Google Scholar
Velazquez JV, Bond NG, Schieffelin JS, Gunn BM. Survivors of Ebola virus disease exhibit elevated levels of autoantibodies. J Immunol. 2023;210(1_Supplement):59.27-59.27.
Zhu L, Jin J, Wang T, Hu Y, Liu H, Gao T, et al. Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity. eLife. 2024;12:RP88122.
Google Scholar
Hartley C, Bavinger JC, Kuthyar S, Shantha JG, Yeh S. Pathogenesis of Uveitis in Ebola Virus Disease Survivors: Evolving Understanding from Outbreaks to Animal Models. Microorganisms. 2020;8(4):594.
Subtil F, Delaunay C, Keita AK, Sow MS, Touré A, Leroy S, et al. Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea. Clin Infect Diseases. 2017;64(12):1788–90.
Deen GF, Broutet N, Xu W, Knust B, Sesay FR, McDonald SLR, et al. Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors – Final Report. N Engl J Med. 2017;377(15):1428–37.
Google Scholar
Mate SE, Kugelman JR, Nyenswah TG, Ladner JT, Wiley MR, Cordier-Lassalle T, et al. Molecular Evidence of Sexual Transmission of Ebola Virus. N Engl J Med. 2015;373(25):2448–54.
Google Scholar
Luo D, Zheng R, Wang D, Zhang X, Yin Y, Wang K, et al. Effect of sexual transmission on the West Africa Ebola outbreak in 2014: a mathematical modelling study. Sci Rep. 2019;9(1):1653.
Google Scholar
Surani A, Marfatia YS, Pal A, Shah R. Ebola virus: An emerging sexually transmissible infection pathogen. Indian J Sex Transm Dis AIDS. 2018;39(1):65–7.
Google Scholar
Vetter P, Fischer WA II, Schibler M, Jacobs M, Bausch DG, Kaiser L. Ebola Virus Shedding and Transmission: Review of Current Evidence. J Infect Dis. 2016;214(suppl_3):S177–84.
Google Scholar
Riesle-Sbarbaro SA, Wibbelt G, Düx A, Kouakou V, Bokelmann M, Hansen-Kant K, et al. Selective replication and vertical transmission of Ebola virus in experimentally infected Angolan free-tailed bats. Nat Commun. 2024;15(1):925.
Google Scholar
Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease. Geneva: World Health Organization; 2020. ISBN-13: 978-92-4-000138-1.
de St. Maurice A, Ervin E, Orone R, Choi M, Dokubo EK, Rollin PE, et al. Care of Ebola Survivors and Factors Associated With Clinical Sequelae—Monrovia, Liberia. Open Forum Infect Dis. 2018;5(10):239.
Henwood PC, Bebell LM, Roshania R, Wolfman V, Mallow M, Kalyanpur A, et al. Ebola Virus Disease and Pregnancy: A Retrospective Cohort Study of Patients Managed at 5 Ebola Treatment Units in West Africa. Clin Infect Diseases. 2017;65(2):292–9.